BioCryst Pharmaceuticals
BCRX
#5073
Rank
ยฃ1.19 B
Marketcap
ยฃ5.69
Share price
-3.07%
Change (1 day)
-7.34%
Change (1 year)

BioCryst Pharmaceuticals (BCRX) - Net assets

Net assets on the balance sheet as of September 2025 : -ยฃ0.3 Billion

According to BioCryst Pharmaceuticals 's latest financial reports the company has -ยฃ0.3 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

BioCryst Pharmaceuticals - Net assets on balance sheet (from 2001 to 2025)

Net assets by year

Year Net assets Change
2024-12-31$-ยฃ0.38 Billion6.07%
2023-12-31$-ยฃ0.36 Billion46.84%
2022-12-31$-ยฃ0.25 Billion207.23%
2021-12-31$-ยฃ79.26 Million460.87%
2020-12-31$-ยฃ14.14 Million-148.44%
2019-12-31$ยฃ29.17 M-24.79%
2018-12-31$ยฃ38.78 M-37.42%
2017-12-31$ยฃ61.98 M4746.52%
2016-12-31$ยฃ1.27 M-96.03%
2015-12-31$ยฃ32.2 M-33.71%
2014-12-31$ยฃ48.58 M-7216.69%
2013-12-31$-ยฃ0.69 Million143.02%
2012-12-31$-ยฃ0.29 Million-102.95%
2011-12-31$ยฃ9.52 M-77.55%
2010-12-31$ยฃ42.43 M-20.4%
2009-12-31$ยฃ53.3 M68.29%
2008-12-31$ยฃ31.67 M-3.04%
2007-12-31$ยฃ32.67 M202.5%
2006-12-31$ยฃ10.8 M-68.13%
2005-12-31$ยฃ33.88 M121.79%
2004-12-31$ยฃ15.27 M-3.92%
2003-12-31$ยฃ15.9 M-36.46%
2002-12-31$ยฃ25.02 M-36.13%
2001-12-31$ยฃ39.18 M

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Repligen
RGEN
ยฃ1.56 B-637.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
ยฃ0.99 B-440.33%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoViricides
NNVC
ยฃ5.63 M-101.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
-ยฃ0.12 Billion-59.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
ยฃ16.09 B-5,631.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
ยฃ0.44 B-254.26%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
ยฃ15.88 B-5,559.29%๐Ÿ‡ฌ๐Ÿ‡ง UK
Emergent BioSolutions
EBS
ยฃ0.43 B-250.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
ยฃ5.26 M-101.81%๐Ÿ‡บ๐Ÿ‡ธ USA